NewAmsterdam Pharma Company NV’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $27.29 on 12/11/24, and the lowest price during that time was $10.12, recorded on 12/18/23.
52-week price history of NAMS Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. NewAmsterdam Pharma Company NV’s current trading price is -2.49% away from its 52-week high, while its distance from the 52-week low is 162.94%. The stock’s price range for this period has remained between $10.12 and $27.29. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.54 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.68 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
NewAmsterdam Pharma Company NV (NAMS) has experienced a quarterly rise of 66.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.78B and boasts a workforce of 29 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.62, with a change in price of +7.75. Similarly, NewAmsterdam Pharma Company NV recorded 606,976 in trading volume during the last 100 days, posting a change of +41.09%.
NAMS Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NAMS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NAMS Stock Stochastic Average
As of today, the raw stochastic average of NewAmsterdam Pharma Company NV over the past 50 days is 93.69%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 92.98%. Additionally, the Stochastic %K and %D values for the company were 79.82% and 77.32%, respectively, over the past 20 days.
NAMS Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 138.23% this year. Over the last six months, there has been a weaker performance of 55.52%. The price of NAMS fallen by 6.87% during the last 30 days period. For the last 5-days stocks have improved 1.60%.
